BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TransPharma Medical Ltd. 

3A Geron Street

Yehud  Tel Aviv  56000  Israel
Phone: 972-3-632-3067 Fax: 972-3-632-3065


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Syneron Medical Ltd. (ELOS) to Acquire Assets of TransPharma Medical Ltd. for $3.6 Million 3/12/2012 7:37:44 AM
TransPharma Medical Ltd. Announces Successful Completion of a Phase 1b Clinical Trial of ViaDor-GLP1 Agonist Indicated for the Treatment of Type II Diabetes 2/22/2011 10:05:04 AM
TransPharma Medical Ltd. Changes the Name of Its Transdermal Drug Delivery System from ViaDerm to ViaDorâ„¢ 1/17/2011 11:30:12 PM
TransPharma Medical Ltd. Announces Successful Results of a Phase 1 Clinical Trial of ViaDerm-Calcitonin for the Treatment of Musculoskeletal Disorders 1/11/2011 9:39:13 AM
TransPharma Medical Ltd. Announces Successful Results of a 4 Week Phase 1 Clinical Trial of Its New Self-applied ViaDerm System for the Treatment of Osteoporosis 10/26/2010 9:52:23 AM
TransPharma Medical Ltd. Announces Successful Completion of Phase 1a Clinical Trial of ViaDerm-GLP1 Agonist Indicated for the Treatment of Type II Diabetes 9/14/2010 7:34:47 AM
TransPharma Medical Ltd. Announces Successful Completion of Phase 2 Trial of ViaDerm-hPTH (1-34) in Postmenopausal Women with Osteoporosis 9/1/2009 10:29:39 AM
TransPharma Medical Ltd. Receives European CE Mark Approval for its Transdermal Drug Delivery Device 12/15/2008 6:24:16 AM
Frost & Sullivan Honours TransPharma Medical Ltd. for its Innovative ViaDerm Drug Delivery System 8/4/2008 9:36:09 AM
Eli Lilly and Company (LLY) and TransPharma Medical Ltd. Announce Licensing and Development Agreement; TransPharma to Receive $35 Million 6/12/2008 6:19:41 AM
12